Company / Return on Equity (ROE)
Yubo International Biotech Ltd Return on Equity (ROE) History
FY2019-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-61.0%
FY2020
5-year range
-61.0% / -61.0%
FY2019-FY2020
Trend
-101.3%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Yubo International Biotech Ltd reports negative total equity of -61.0% in FY2020. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-61.0% in FY2020.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2020, return on equity (roe) decreased 101.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2020 | -61.0% | -101.3% |
| FY2019 | -30.3% | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2020 · SEC 10-K · Updated Jun 29, 2026